Article
Role of the p16 tumor suppressor gene in cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Mar 1998
Liggett W H, Sidransky D
Abstract excerpt
Since its discovery as a CDKI (cyclin-dependent kinase inhibitor) in 1993, the tumor suppressor p16 (INK4A/MTS-1/CDKN2A) has gained widespread importance in cancer. The frequent mutations and deletions of p16 in human cancer cell lines first suggested an important role for p16 in carcinogenesis. This genetic evidence for a causal role was significantly strengthened by the observation that p16 was frequently...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
